Shalby Ltd
Shalby Ltd is engaged in healthcare delivery space in India. It operates a chain of multi-specialty hospitals across India. The business of the company is to offer tertiary and quaternary healthcare services to patients in various areas of specialization such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, renal transplantations, etc.[1]
The company is the global leader in knee replacement surgery and one of the top Indian hospitals in joint replacement surgery.
- Market Cap ₹ 2,330 Cr.
- Current Price ₹ 216
- High / Low ₹ 340 / 204
- Stock P/E 44.6
- Book Value ₹ 93.2
- Dividend Yield 0.56 %
- ROCE 11.0 %
- ROE 8.16 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 20.0% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 18.1%
Cons
- Company has a low return on equity of 7.39% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Part of BSE SmallCap BSE Healthcare BSE Allcap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
259 | 275 | 290 | 324 | 378 | 462 | 487 | 431 | 699 | 805 | 934 | 1,007 | |
196 | 207 | 235 | 252 | 299 | 379 | 404 | 342 | 577 | 667 | 755 | 848 | |
Operating Profit | 63 | 68 | 56 | 71 | 79 | 83 | 83 | 89 | 122 | 138 | 179 | 159 |
OPM % | 24% | 25% | 19% | 22% | 21% | 18% | 17% | 21% | 17% | 17% | 19% | 16% |
2 | 2 | 2 | 7 | 10 | 9 | 17 | 8 | 8 | 22 | 19 | 26 | |
Interest | 2 | 5 | 10 | 11 | 12 | 9 | 7 | 5 | 8 | 11 | 18 | 27 |
Depreciation | 11 | 21 | 11 | 17 | 23 | 33 | 36 | 37 | 43 | 48 | 52 | 61 |
Profit before tax | 52 | 43 | 36 | 50 | 54 | 50 | 57 | 55 | 79 | 102 | 128 | 97 |
Tax % | 28% | 43% | -1% | 43% | 27% | 37% | 51% | 23% | 32% | 34% | 35% | |
38 | 25 | 36 | 29 | 39 | 32 | 28 | 42 | 54 | 68 | 84 | 52 | |
EPS in Rs | 11.17 | 7.36 | 4.30 | 3.40 | 3.65 | 2.93 | 2.55 | 3.93 | 5.01 | 6.27 | 7.78 | 5.07 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 17% | 20% | 25% | 20% | 19% | 15% |
Compounded Sales Growth | |
---|---|
10 Years: | 14% |
5 Years: | 15% |
3 Years: | 29% |
TTM: | 15% |
Compounded Profit Growth | |
---|---|
10 Years: | 8% |
5 Years: | 20% |
3 Years: | 22% |
TTM: | -33% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 14% |
3 Years: | 15% |
1 Year: | -31% |
Return on Equity | |
---|---|
10 Years: | 7% |
5 Years: | 6% |
3 Years: | 7% |
Last Year: | 8% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 35 | 35 | 87 | 87 | 108 | 108 | 108 | 108 | 108 | 107 | 107 | 107 |
Reserves | 106 | 133 | 117 | 164 | 643 | 672 | 691 | 727 | 768 | 820 | 893 | 899 |
37 | 98 | 224 | 328 | 114 | 71 | 62 | 44 | 155 | 180 | 378 | 463 | |
39 | 85 | 75 | 99 | 96 | 89 | 105 | 118 | 162 | 173 | 231 | 247 | |
Total Liabilities | 217 | 351 | 504 | 679 | 961 | 939 | 967 | 997 | 1,194 | 1,281 | 1,609 | 1,717 |
130 | 175 | 319 | 323 | 650 | 692 | 672 | 660 | 675 | 685 | 966 | 971 | |
CWIP | 5 | 91 | 82 | 221 | 47 | 3 | 6 | 8 | 6 | 11 | 15 | 11 |
Investments | 0 | 0 | 0 | 0 | 0 | 11 | 28 | 16 | 25 | 146 | 81 | 112 |
81 | 85 | 102 | 134 | 264 | 233 | 260 | 314 | 488 | 440 | 547 | 623 | |
Total Assets | 217 | 351 | 504 | 679 | 961 | 939 | 967 | 997 | 1,194 | 1,281 | 1,609 | 1,717 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|
60 | 14 | 43 | 55 | 79 | 19 | 68 | 20 | ||||
-153 | -236 | 1 | -31 | -51 | -60 | -61 | 146 | ||||
96 | 222 | -51 | -22 | -30 | 90 | -50 | -151 | ||||
Net Cash Flow | 3 | 0 | -6 | 3 | -2 | 49 | -43 | 15 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 21 | 29 | 40 | 38 | 49 | 64 | 71 | 80 | 53 | 48 | 57 |
Inventory Days | 77 | 113 | 119 | 105 | 242 | 1,152 | 1,361 | ||||
Days Payable | 395 | 462 | 522 | 415 | 606 | 546 | 744 | ||||
Cash Conversion Cycle | 21 | 29 | 40 | -280 | -299 | -339 | -239 | -283 | 53 | 654 | 673 |
Working Capital Days | 35 | -46 | -26 | -34 | -3 | 57 | 70 | 84 | 109 | 111 | 107 |
ROCE % | 22% | 13% | 12% | 9% | 7% | 7% | 7% | 10% | 10% | 11% |
Documents
Announcements
-
Disclosure Under Regulation 29(2) Of Securities Exchange Board Of India (Substantial Acquisition Of Shares And Takeover) Regulations, 2011
15 Nov - Disclosure of acquisition of 25,000 equity shares.
-
Disclosure Under Regulation 7(2) Of Securities Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015
15 Nov - Disclosure of purchase of 25,000 equity shares by promoter.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
6 Nov - Transcript of Q2 FY 2025 Earning Call held on 30th October 2024
-
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
5 Nov - Of Exercise of 3,000 Stock options under Shalby Limited Stock Options Scheme-2021
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
31 Oct - Copy of newspaper advertisement for publication of Unaudited financial results for quarter and half year ended September 30, 2024
Annual reports
Concalls
-
Nov 2024Transcript PPT
-
Jul 2024Transcript PPT
-
Jun 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Jul 2023Transcript PPT
-
May 2023Transcript PPT
-
Jan 2023Transcript PPT
-
Oct 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Dec 2021Transcript PPT
-
Oct 2021TranscriptNotesPPT
-
Aug 2021Transcript PPT
-
Jun 2021Transcript PPT
-
May 2021Transcript PPT
-
May 2021TranscriptNotesPPT
-
May 2021TranscriptNotesPPT
-
Jan 2021Transcript PPT
-
Jan 2021TranscriptNotesPPT
-
Oct 2020TranscriptPPT
-
Oct 2020Transcript PPT
-
Sep 2020TranscriptNotesPPT
-
Jun 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Jul 2019Transcript PPT
-
May 2019Transcript PPT
-
Jan 2019Transcript PPT
-
Oct 2018Transcript PPT
-
Aug 2018Transcript PPT
-
May 2018TranscriptNotesPPT
-
Mar 2018TranscriptNotesPPT
Hospitals Portfolio
The co. operates 14 hospitals across India with a total bed capacity of 2,000+ beds. It also owns 60 outpatient clinics across 16 states in India and 5 OP clinics in African Countries. [1] [2] The co. has two upcoming facilities with a combined capacity of 321 beds will be located in Maharashtra. [3]